NewLink Genetics (NLNK) Tops Q4 EPS by 17c

NewLink Genetics (NASDAQ: NLNK) reported Q4 EPS of ($0.75), $0.17 better than the analyst estimate of ($0.92). Revenue for the quarter came in at $6.06 million versus the consensus estimate of $4.89 million.

For earnings history and earnings-related data on NewLink Genetics (NLNK) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Reading (RDI) Tops Q2 EPS by 4c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c